WEBSITE BSE:0 NSE: Inc. Year: 1995 Industry: Household & Personal Products My Bucket: Add Stock
Last updated: 15:40
No Notes Added Yet
Transteel Seating Technologies Limited is a company that produces and supplies office furniture, such as chairs, workstations, desks, tables, and storage units. Iincorporated in 1995, it is the flagship company of the Bhutoria Group, which has a business legacy of over 100 years. The company is headquartered in Bangalore and has seven experience centers across India. Company is ISO 9001 and ISO 27001 certified and has a reputation for quality, durability, and customer satisfaction. Offers a wide range of products, from budget-friendly to premiu...Read More
Transteel Seating Technologies Limited is a company that produces and supplies office furniture, such as chairs, workstations, desks, tables, and storage units. Iincorporated in 1995, it is the flagship company of the Bhutoria Group, which has a business legacy of over 100 years. The company is headquartered in Bangalore and has seven experience centers across India. Company is ISO 9001 and ISO 27001 certified and has a reputation for quality, durability, and customer satisfaction. Offers a wide range of products, from budget-friendly to premium, and also provides customized solutions according to the client’s needs and preferences. The company serves in various sectors, such as corporate, government, education, and healthcare. The company also leverages technology and innovation to create workspaces that inspire productivity and well-being. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹280 Cr.
Stock P/E 22.1
P/B 3.3
Current Price ₹138.7
Book Value ₹ 41.8
Face Value 10
52W High ₹169
Dividend Yield 0%
52W Low ₹ 106.2
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) |
|---|
| Net Sales |
| Other Income |
| Total Income |
| Total Expenditure |
| Operating Profit |
| Interest |
| Depreciation |
| Exceptional Income / Expenses |
| Profit Before Tax |
| Provision for Tax |
| Profit After Tax |
| Adjustments |
| Profit After Adjustments |
| Adjusted Earnings Per Share |
| #(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|
| Net Sales | 23 | 28 | 59 | 74 | 89 | |
| Other Income | 0 | 0 | 0 | 0 | 0 | |
| Total Income | 23 | 28 | 60 | 75 | 89 | |
| Total Expenditure | 21 | 24 | 44 | 55 | 66 | |
| Operating Profit | 2 | 4 | 16 | 20 | 22 | |
| Interest | 1 | 1 | 3 | 4 | 3 | |
| Depreciation | 1 | 1 | 1 | 1 | 1 | |
| Exceptional Income / Expenses | -0 | 0 | -0 | 0 | 0 | |
| Profit Before Tax | 0 | 2 | 13 | 15 | 18 | |
| Provision for Tax | 0 | 1 | 3 | 4 | 5 | |
| Profit After Tax | -0 | 2 | 9 | 11 | 13 | |
| Adjustments | 0 | 0 | 0 | 0 | 0 | |
| Profit After Adjustments | -0 | 2 | 9 | 11 | 13 | |
| Adjusted Earnings Per Share | -0 | 2.9 | 6.8 | 5.5 | 6.3 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 20% | 47% | 0% | 0% |
| Operating Profit CAGR | 10% | 77% | 0% | 0% |
| PAT CAGR | 18% | 87% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 27% | NA% | NA% | NA% |
| ROE Average | 15% | 32% | 25% | 25% |
| ROCE Average | 17% | 28% | 23% | 23% |
| #(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Shareholder's Funds | 5 | 6 | 24 | 78 | 100 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 2 | 4 | 16 | 10 | 14 |
| Other Non-Current Liabilities | 1 | 1 | 1 | 1 | 1 |
| Total Current Liabilities | 18 | 26 | 43 | 54 | 47 |
| Total Liabilities | 25 | 36 | 83 | 142 | 162 |
| Fixed Assets | 4 | 4 | 4 | 4 | 18 |
| Other Non-Current Assets | 5 | 13 | 28 | 33 | 34 |
| Total Current Assets | 16 | 19 | 51 | 105 | 110 |
| Total Assets | 25 | 36 | 83 | 142 | 162 |
| #(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 1 | 1 | 1 | 0 | 0 |
| Cash Flow from Operating Activities | 2 | 6 | -4 | -42 | 8 |
| Cash Flow from Investing Activities | -5 | -8 | -16 | -5 | -16 |
| Cash Flow from Financing Activities | 3 | 2 | 20 | 47 | 9 |
| Net Cash Inflow / Outflow | -0 | 0 | 0 | -0 | 1 |
| Closing Cash & Cash Equivalent | 1 | 1 | 1 | 0 | 1 |
| # | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Earnings Per Share (Rs) | -0.01 | 2.9 | 6.79 | 5.51 | 6.28 |
| CEPS(Rs) | 1.1 | 4.02 | 7.31 | 5.88 | 6.97 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 8.59 | 11.5 | 18.25 | 38.59 | 44.87 |
| Core EBITDA Margin(%) | 8.12 | 14.92 | 26.54 | 26.26 | 25.03 |
| EBIT Margin(%) | 5.64 | 13.02 | 25.41 | 25.75 | 23.78 |
| Pre Tax Margin(%) | 0.79 | 7.8 | 21.08 | 20.2 | 19.84 |
| PAT Margin (%) | -0.03 | 5.68 | 15.29 | 14.97 | 14.29 |
| Cash Profit Margin (%) | 2.63 | 7.87 | 16.47 | 15.98 | 15.86 |
| ROA(%) | -0.02 | 5.18 | 15.23 | 9.85 | 8.32 |
| ROE(%) | -0.13 | 28.91 | 59.17 | 21.72 | 15.04 |
| ROCE(%) | 8.82 | 21.33 | 42.63 | 23.24 | 16.79 |
| Receivable days | 38.4 | 43.48 | 69.29 | 83.71 | 68.48 |
| Inventory Days | 189.7 | 162.08 | 113.65 | 102.77 | 97.02 |
| Payable days | 287.71 | 303.19 | 250.15 | 180.36 | 110.63 |
| PER(x) | 0 | 0 | 0 | 10.9 | 15.08 |
| Price/Book(x) | 0 | 0 | 0 | 1.56 | 2.11 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.39 | 0.44 | 0.44 | 2.09 | 2.55 |
| EV/Core EBITDA(x) | 4.68 | 2.9 | 1.64 | 7.81 | 10.06 |
| Net Sales Growth(%) | 0 | 22.7 | 112.51 | 24.84 | 19.38 |
| EBIT Growth(%) | 0 | 183.23 | 314.89 | 26.5 | 10.25 |
| PAT Growth(%) | 0 | 0 | 471.64 | 22.2 | 13.97 |
| EPS Growth(%) | 0 | 0 | 133.7 | -18.88 | 13.97 |
| Debt/Equity(x) | 2.1 | 2.11 | 1.1 | 0.45 | 0.42 |
| Current Ratio(x) | 0.88 | 0.75 | 1.19 | 1.94 | 2.34 |
| Quick Ratio(x) | 0.23 | 0.24 | 0.63 | 1.61 | 1.72 |
| Interest Cover(x) | 1.16 | 2.49 | 5.86 | 4.64 | 6.03 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0.29 | 0.2 |
| # | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Promoter | 51.28 | 51.29 | 44.35 | 41.23 | 40.51 |
| FII | 1.24 | 0.02 | 2.81 | 9.93 | 10.77 |
| DII | 2.71 | 0.6 | 0 | 0 | 2.35 |
| Public | 44.78 | 48.09 | 52.84 | 48.84 | 46.37 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Promoter | 1.03 | 1.03 | 0.89 | 0.89 | 0.89 |
| FII | 0.03 | 0 | 0.06 | 0.22 | 0.24 |
| DII | 0.05 | 0.01 | 0 | 0 | 0.05 |
| Public | 0.9 | 0.97 | 1.07 | 1.06 | 1.02 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Total | 2.02 | 2.02 | 2.02 | 2.17 | 2.21 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.